Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients

INTRODUCTION: To compare the prognosis of adjuvant SOX (S-1 and oxaliplatin) vs XELOX (capecitabine and oxaliplatin) chemotherapy in Chinese patients with gastric cancer (GC) after D2 gastrectomy. METHODS: This was a real-world study of patients with GC (stages II–III) who underwent D2 gastrectomy a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Manag Res
Egile Nagusiak: Yu, Shan, Wang, Yan, Cheng, Xi, Lv, Minzhi, Cui, Yuehong, Li, Wei, Yu, Yiyi, Li, Qian, Liu, Tianshu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7568598/
https://ncbi.nlm.nih.gov/pubmed/33116865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S270387
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak